跳至主要内容
临床试验/ISRCTN29738990
ISRCTN29738990已完成未知

A single-centre, four-arm, randomised parallel trial of healthy eating, aerobic exercise and resistance training to reduce percent body fat in overweight or obese adolescents

Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute0 个研究点目标入组 292 人开始时间: 2007年6月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
292

研究概览

简要总结

2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/30363954 [added 20/02/2019]

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Male or female
  • 2. Aged 14 to 18 years
  • 3. Tanner stage IV or above
  • 4. Body mass index (BMI) greater than or equal to 95th percentile for age, and gender (http://www.cdc.gov/growthcharts),
  • greater than or equal to 85th percentile for age/gender with any of:
  • 4.1. Fasting glucose greater than or equal to 6.0 fasting
  • 4.2. Two-hour plasma glucose 7.8 - 11 mmol/L after 75 G oral glucose (impaired glucose tolerance)
  • 4.3. Fasting triglycerides greater than 1.7 mmol/L
  • 4.4. Fasting plasma insulin greater than 105 pmol/L
  • 4.5. High density lipoprotein-cholesterol (HDL-C) less than 0.9 mmol/L
  • 4.6. Low density lipoprotein-cholesterol (LDL-C) greater than 3.0 mmol/L
  • 4.7. Total cholesterol/HDL-C greater than 90th percentile
  • 4.8. First-degree relative with type 2 diabetes

排除标准

  • 1. Participation during the previous four months in a regular program of exercise or aerobic sports greater than or equal to two times per week for at least 20 minutes per session
  • 2. Diabetes mellitus
  • 3. Body weight over 159 kg, and/or BMI greater than 45 kg/m^2, exceeding capacity of dual energy X-ray absorptiometry (DEXA) and computed tomography (CT) machines
  • 4. Use of any performance-enhancing medication
  • 5. Use of any medication or herbal supplement that is likely to affect body composition, lipids or glucose metabolism
  • 6. Significant weight change (increase of greater than or equal to 10%, or decrease greater than or equal to 5% of body weight during the two months before enrolment)
  • 7. Uncontrolled hypertension: blood pressure (BP) greater than 150 mmHg systolic or greater than 95 mmHg diastolic BP in sitting position
  • 8. Activity restrictions due to disease: unstable cardiac or pulmonary disease, significant arthritis
  • 9. Other illness judged by the patient or study physician to make participation in this study inadvisable
  • 10. Unwillingness/lack of availability to attend exercise and/or nutrition sessions at scheduled times and locations
  • 11. Significant cognitive deficit resulting in inability to understand or comply with instructions
  • 12. Pregnancy at the start of the study, or intention to become pregnant in the next year
  • 13. Inability to communicate in English or French
  • 14. Unwillingness of subject and/or parent/guardian to sign informed consent

研究者

发起方
Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute

相似试验

The Healthy Eating, Aerobic and Resistance Training... | 临床试验